NeuroBo Pharmaceuticals Free Cash Flow (Quarterly) Analysis

NeuroBo Pharmaceuticals Inc (NRBO)

2.30 -0.09 (-3.77%) USD | NASDAQ | Nov 15, 11:28

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
September 30, 2024	-5.589M
June 30, 2024	-7.254M
March 31, 2024	-6.447M
December 31, 2023	-3.402M
September 30, 2023	-2.851M
June 30, 2023	-2.045M
March 31, 2023	-2.551M
December 31, 2022	-1.807M
September 30, 2022	-2.359M
June 30, 2022	-2.717M
March 31, 2022	-4.829M
December 31, 2021	-2.899M
September 30, 2021	-2.507M
June 30, 2021	-3.59M
March 31, 2021	-6.141M
December 31, 2020	-2.35M
September 30, 2020	-1.954M
June 30, 2020	-2.324M
March 31, 2020	-4.14M
December 31, 2019	-1.374M

Date	Value
September 30, 2019	-3.438M
June 30, 2019	-1.217M
March 31, 2019	-1.224M
December 31, 2018	3.347M
September 30, 2018	-4.284M
June 30, 2018	-6.278M
March 31, 2018	-7.236M
December 31, 2017	-6.76M
September 30, 2017	-7.299M
June 30, 2017	-6.619M
March 31, 2017	-6.223M
December 31, 2016	-3.623M
September 30, 2016	-3.634M
June 30, 2016	-1.73M
March 31, 2016	-2.056M
December 31, 2015	-2.256M
September 30, 2015	-1.562M
June 30, 2015	-0.995M
March 31, 2015	-0.62M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-7.254M

Minimum

Jun 2024

-1.374M

Maximum

Dec 2019

-3.456M

Average

-2.784M

Median

Free Cash Flow (Quarterly) Benchmarks